Company profile: Hemanext
1.1 - Company Overview
Company description
- Provider of blood processing, storage, and transfusion solutions. Offers Hemanext ONE, a blood container set for processing and storing red blood cells under reduced oxygen and carbon dioxide conditions to improve quality and extend shelf-life.
Products and services
- Blood Processing Solution: Delivers processing of red blood cells with reduced oxygen and carbon dioxide exposure to enhance stored blood quality
- Carbon-dioxide–controlled
- Blood Storage and Transfusion Solution: Offers storage and transfusion of blood optimized by reduced oxygen and carbon dioxide conditions to extend shelf-life and quality
- RBC-specific
- Hemanext ONE: Engineers a blood container set that processes and stores red blood cells under reduced oxygen and carbon dioxide conditions to improve stored blood quality and shelf-life
- Oxygen-reduced
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hemanext
Indigo Biosciences
HQ: United States
Website
- Description: Provider of nuclear receptor-focused products and services addressing therapeutic drug targets, including cell-based luciferase reporter assay kits for GPCR and nuclear receptors, Live Cell Multiplex assays to quantify live cells alongside nuclear receptor assays, INDIGlo luciferase detection reagent, environmental testing bioassays, and an ortholog assay portfolio for cross-species receptor activity comparison aiding selection of animal models for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo Biosciences company profile →
MicroLiquid
HQ: Spain
Website
- Description: Provider of contract development and manufacturing of polymer microfluidic disposable devices and life science microfluidic products for worldwide customers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MicroLiquid company profile →
Groupe Carso
HQ: France
Website
- Description: Provider of environmental and agrifood analytical services, including testing of water and environmental elements (soils, waste, biomass, emissions, air quality), food and animal nutrition sampling and analyses, industrial hygiene and building health services (chemical risk, pollutant concentrations, radioprotection), forensic analyses (genetic/digital fingerprinting, blood trace, electronic/computer evidence), high-throughput DNA sequencing, and lab outsourcing support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Groupe Carso company profile →
Cellesce
HQ: United Kingdom
Website
- Description: Provider of patient-derived organoid (PDO) technology and 3D organoids for drug discovery assays, offering fee-for-service custom development and scaled manufacturing of PDO lines, plus comprehensive enablement services including sourcing, line development, technology access, and quality management systems. Biochemical engineering expertise in cell expansion; based in Cardiff, UK.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellesce company profile →
Luxendo
HQ: Germany
Website
- Description: Provider of proprietary light-sheet fluorescence microscopy instruments based on Single Plane Illumination Microscopy (SPIM). Offers MuVi SPIM, InVi SPIM Lattice Pro, LCS SPIM, and TruLive3D Imager, plus Acquifer HIVE for centralized data storage and computing and LuxBundle Software for acquisition, viewing, and post-processing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luxendo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hemanext
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hemanext
2.2 - Growth funds investing in similar companies to Hemanext
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hemanext
4.2 - Public trading comparable groups for Hemanext
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →